Financial News · Live Terminal

Page 272 of 302

Evolution Mining Confirms Mineralization Extension at Western Australia Prospects

Evolution Mining (ASX:EVN) confirmed extensions of high-grade mineralization at the Genesis and Arctic prospects within the Mungari gold operation in Western Australia, according to a Wednesday filing with the Australian bourse.Intercepts identified extended mineralized corridors near existing infrastructure, indicating potential for underground mine life extensions at current production rates, the filing said.Meanwhile, high-grade results were identified from the Oban underground target, along with "encouraging" findings beyond the pit outline at E41 at Cowal in New South Wales, per the filing.

$ASX:EVN

Asia25d ago

Forrestania Resources Says Drilling At Malawi Niobium Project Confirms Mineralization Associated With Soil Anomaly

Forrestania Resources (ASX:FRS) said maiden reverse circulation at the Wozi niobium project in Malawi confirmed high-grade, near-surface niobium mineralization, associated with an over 1.5 kilometers long and up to 400 meters wide niobium soil anomaly, according to a Wednesday Australian bourse filing.It encountered intercepts of 36 meters at 0.56% grade of niobium pentoxide from the surface, as well as 16 meters at 0.42% grade of niobium pentoxide from 52 meters.

$ASX:FRS

Asia25d ago

Tivan, Sumitomo Agree To Extend Northern Territory Tungsten Project Memorandum of Understanding Term

Tivan (ASX:TVN) and Sumitomo agreed to extend the term of their existing memorandum of understanding for the Molyhil tungsten project in the Northern Territory to June 30 from Wednesday, according to a same-day Australian bourse filing.The firms have advanced discussions on a potential joint venture structure for the project and have begun early-stage marketing of the project. Tivan agreed to provide product samples from the project to potential customers and is targeting delivery in the September quarter.Tivan also advanced preliminary discussions with third parties on joining a key terms memorandum of understanding as potential joint venture partners, with the consent of Sumitomo.

$ASX:TVN

Asia25d ago

Avita Medical Reports Positive Interim Results From Cohealyx-I Wound Care Study

Avita Medical (ASX:AVH) said interim results from its Cohealyx-I multi-center study showed a reduction of nearly 20 days in the mean time to skin grafting, at 13.6 days compared with a 33.2-day real-world benchmark, for patients with full-thickness wounds, according to a Wednesday Australian bourse filing.The study's primary endpoint is time to autografting, and the secondary endpoints include wound healing and safety outcomes, per the filing.The company said the interim analysis of 40 patients showed a median time to grafting of 11 days, with grafting achieved as early as five days, 25% of patients grafted within seven days, and 72% grafted within 14 days.The study is ongoing, with the full dataset expected this year.

$ASX:AVH

Asia25d ago

Qantas Airways Fuel Guidance Revision In-Line With Expectations, Says Jefferies

Qantas Airways' (ASX:QAN) revised fuel expense and earnings guidance are in line with expectations, Jefferies said in a note on Tuesday, adding that the airline appears insulated from any material impact from the war in West Asia.The company increased its second-half fuel outlook to a range of AU$3.1 billion to AU$3.3 billion from AU$2.5 billion previously, broadly aligning with Jefferies' estimate of AU$3.19 billion. Domestic revenue per available seat kilometer (RASK) is projected to grow by 5% in the period, up from prior guidance of around 3%.The investment firm noted that while current demand levels are expected to hold, any future weakness would likely be offset by lower capacity.Jefferies said it expects the company to cancel its AU$150 million interim share buyback and another buyback expected at its fiscal year 2026 result to retain cash to strengthen its balance sheet.The brokerage will review its fuel forecasts in a few weeks once May refinery margin data becomes available, it added.Jefferies maintained a buy rating on Qantas with a price target of AU$12.80.

$ASX:QAN

Asia25d ago

Telix Pharmaceuticals Upsizes Convertible Notes Due 2031 to $600 Million

Telix Pharmaceuticals (ASX:TLX) successfully priced and upsized its 1.50% convertible notes due 2031 to $600 million from $550 million, issued through its wholly owned subsidiary, Telix Pharmaceuticals Investments, reflecting strong investor demand, according to a Wednesday Australian bourse filing.The notes can be converted into the company's ordinary shares at an initial conversion price of $13.85, which reflects a premium of around 38% over the reference share price, per the filing.The bonds pay interest quarterly and mature around April 2031, unless they are redeemed or converted earlier, the filing said.The company will simultaneously repurchase and cancel over 85% of its 2029 convertible bonds through a reverse bookbuild process, with settlement for both transactions expected on April 22, the filing added.

$ASX:TLX

Asia25d ago

Alcoa Unit to Redeem $219 Million Notes Due 2028

Alcoa (ASX:AAI) said that its wholly owned subsidiary, Alcoa Nederland, has issued a notice to redeem all $219 million of its outstanding 6.125% senior notes due in 2028, according to a Wednesday statement from the company.The redemption price will be 100% of the principal amount plus accrued and unpaid interest up to the redemption date, and the repayment will be funded using the company's existing cash reserves.

$ASX:AAI

Asia25d ago

Westpac Banking's Downward Annual Guidance Signals Caution as Credit Conditions Hold, Says Jefferies

Westpac Banking (ASX:WBC, NZE:WBC) is faring well with solid fundamentals, but its recent annual earnings guidance cut calls for a cautionary glance on weaker net interest margin, Jefferies said in a note on Tuesday.The bank revised its fiscal 2026 earnings per share down by 3%, dragged down by lower first-half net interest margin due to reduced markets and treasury contribution, one-off costs from the sale of its RAMS mortgage portfolio, and higher loan impairment charges.The investment firm said that provisions increased despite improving asset quality, pointing to a more defensive macroeconomic stance.Analysts at Jefferies also expect Westpac's New Zealand segment to be negatively affected by currency weakness in the first half, creating a modest headwind to earnings.Jefferies reaffirmed a hold rating on Westpac Banking and lifted the price target to AU$34.92 from AU$34.88.

$ASX:WBC$NZE:WBC

Asia25d ago

Ryman Healthcare's Total Fiscal Q4 Sales Volumes Rise

Ryman Healthcare (ASX:RYM, NZE:RYM) reported 331 occupation right agreement (ORA) sales in the fiscal fourth quarter, up 10% from 302 a year earlier, according to a Wednesday filing with the Australian and New Zealand bourses.The total sales for the quarter ended March 31, include 81 new sales and 250 resales, compared with 83 new sales and 219 resales a year earlier.Occupancy at mature care centers held steady at 96.1% in the fourth quarter, while newer centers outperformed expectations, with four of five opened in the past two years exceeding 80% occupancy as of March 31, per the filing.The company's fiscal 2026 free cash flow is expected to be around NZ$180 million, while net interest-bearing debt stood at NZ$1.57 billion as at March 31, the filing added.

$ASX:RYM$NZE:RYM

Asia25d ago

Channel Infrastructure Says Fuel Throughput Rises in Q1

Channel Infrastructure (NZE:CHI, ASX:CHI) said that its fuel throughput rose 2% to 931 million liters for the quarter ended March 31, compared with 915 million liters a year earlier, according to a Wednesday filing with the New Zealand bourse.The jet, diesel, and petrol throughput in the quarter were 404 million, 276 million, and 251 million liters, respectively, compared with 381 million, 261 million, and 273 million liters a year earlier.Thirteen import shipments were received during the quarter, unchanged from the number of ship movements in the prior corresponding period.Net borrowings increased to NZ$338 million as of March 31, with conversion spending staying within budget at NZ$192 million.

$ASX:CHI$NZE:CHI

Asia25d ago

Auckland International Airport's Total Passenger Movements Up 6% in March

Auckland International Airport (ASX:AIA, NZE:AIA) recorded 1.7 million passenger movements in March, up 6% year on year, according to a Wednesday filing with the New Zealand bourse.Total passenger movements for the financial year to date reached 14.8 million in March, marking a 3% year-on-year increase, per the filing.Total international passenger movements rose 8% to 927,993, the filing added.Excluding transits, international passenger movements increased by 8%. International seat capacity grew 2%, resulting in average load factors of 86%, a 4.4 percentage-point increase year on year, the company said.Domestic passenger movements rose 3% to 791,057.

$ASX:AIA$NZE:AIA

Asia26d ago

Imagi International Gets New Substantial Shareholder, Chair

Imagi International (HKG:0585) said Han Xuyang acquired nearly 141.9 million, or 17.1%, shares in the firm from substantial shareholder and single largest shareholder Oshidori International Holdings, according to a Tuesday Hong Kong bourse filing.Following completion, Oshidori International ceased to be a substantial shareholder and Han became a substantial shareholder and the single largest shareholder with 17.1% shares.Han was also named as the integrated financial services firm's chairman effective Tuesday. Han has been the CEO of CST Group, which was previously listed on the Hong Kong bourse, since 2022.

$HKG:0585

Asia26d ago

Genscript Biotech Associate Logs $597 Million in Q1 Sales of Carvykti

Genscript Biotech (HKG:1548) associate Legend Biotech said Carvykti generated around $597 million in net trade sales in the quarter ended March 31, according to a Tuesday Hong Kong bourse filing.The sales were recorded under a collaboration and license agreement between Legend Biotech and Janssen Biotech dated Dec. 21, 2017.

$HKG:1548

Asia26d ago

InSilico Medicine Grants 3.7 Million RSUs Under Incentive Scheme

InSilico Medicine (HKG:3696) granted a little over 3.7 million restricted share units (RSUs) to certain participants under a post-IPO RSU scheme, according to a Tuesday Hong Kong bourse filing.The granting of the RSUs is subject to the fulfillment of the relevant performance targets, the AI-driven drug discovery and development company said.The firm now has around 24.2 million shares available for future grants under its RSU and share option incentive plans, of which 2.8 million shares will be available for future grant to service providers within the scheme mandate limit.

$HKG:3696

Asia26d ago

BrainAurora Medical Technology's Chair Plans Shareholding Increase

BrainAurora Medical Technology (HKG:6681) said its chairman and controlling shareholder, Tan Zheng, plans to acquire additional shares in the company worth up to HK$80 million, according to a Tuesday Hong Kong bourse filing.The purchases will be made from the open market over six months directly or through entities controlled by Tan.Tan and parties acting in concert with him are currently interested in a little over 459.4 million, or 33.83%, shares in the digital diagnostics and therapies provider.

$HKG:6681

Asia26d ago

China Datang Renewable Power's Output Slides 21% in March

China Datang Renewable Power's (HKG:1798) power generation in March slipped 21% year over year to nearly 2.8 million megawatt-hours, according to a Tuesday Hong Kong bourse filing.Of the total, wind power output slipped 26% to 2.3 million megawatt-hours, while photovoltaic power generation jumped 22% to 455,301 megawatt-hours.As of March 31, total output fell 9.4% to 8.9 million megawatt-hours. Of this, wind power generation declined 13% to 7.7 million megawatt-hours and photovoltaic power generation increased 21% to 1.2 million megawatt-hours.

$HKG:1798

Asia26d ago

Cloud Factory Technology, Directors Censured by Hong Kong Bourse Over Disclosure Discrepancies

Cloud Factory Technology (HKG:2512) and four directors have been subjected to a censure imposed by the Hong Kong Stock Exchange, according to a Tuesday filing by the bourse.The action comes as a result of material discrepancies found between disclosures in profit and working capital forecast submitted to the bourse in June 2024, and a prospectus published earlier the same month.The censured individuals comprise CEO Sun Tao, executive directors Jiang Yanqiu and Ji Lijun, and former executive Director Zhu Wentao.The bourse has directed the data center services provider to appoint a compliance adviser for two years, and Sun, Jiang, Ji to attend 18 hours of training on regulatory and legal topics and Listing Rule compliance.Zhu has been instructed to attend 18 hours of training as a pre-requisite of any future director appointment of a listed firm.

$HKG:2512

Asia26d ago

China Southern Airlines Passenger Capacity Jumps 12% in March

China Southern Airlines (SHA:600029, HKG:1055) passenger capacity jumped 12% year over year to 32.9 billion available seat kilometers in March, according to a Tuesday filing with the Hong Kong bourse.Passenger count climbed 10% to 14.6 million in the month.Cargo capacity increased 3.8% to 1.62 billion available ton-kilometers, the airline said in its filing.Cargo and mail carried edged up 0.2% to 159,260 tons.

$HKG:1055$SHA:600029

Asia26d ago

Pateo Connect Receives Letter of Intent for $1 Billion Support for Mergers, Acquisitions

Pateo Connect Technology (Shanghai) (HKG:2889) said Ping An Capital issued a letter of intent for strategic mergers and acquisitions, according to a Tuesday Hong Kong bourse filing.Ping An Capital is indicating its preliminary intent to provide the firm with up to $1 billion in financial support for mergers and acquisitions, amalgamation, and project consultancy over the next five years.

$HKG:2889

Asia26d ago

COFCO Joycome Foods Unit, Associate Engage Huazhong Agricultural University for Tech R&D

COFCO Joycome Foods (HKG:1610) unit Wuhan COFCO Meat Product and associate COFCO, as joint entrusting parties, entered into a technology development contract with Huazhong Agricultural University, according to a Tuesday Hong Kong bourse filing.Under the contract that began April 1, 2026, and will end April 1, 2029, Huazhong Agricultural University will carry out technology R&D related to hog breeding for the entrusting parties for 60 million yuan.The intellectual property rights of any R&D results under the project will be owned 25% each by Wuhan COFCO Meat Product and COFCO, and 50% by the university.COFCO owns COFCO (Hong Kong), which is a substantial shareholder of COFCO Joycome Foods.

$HKG:1610

Showing 5421-5440 of 6028